Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Ramipril
Trade Name
Tritace
Manufacturer
Aventis Pharma
Risk Category
D*
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
The risk category is C in the first trimester.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • Angiotensin - converting enzyme inhibitor.
  • antihypertensive.
  • Fetal Risk
    Fetal Risk
  • The use of angiotensin converting enzyme inhibitors in general during the second and third trimesters is associated with skull defects (hypocalvaria), renal defects, decreased renal perfusion leading to oligohydramnios and neonatal hypotension and anuria.
  • No data about the use of this drug in human pregnancy.
  • Breast Feeding
    Breast Feeding
  • Women receiving Ramipril should not breast feed.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     4   +   3    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year